Innovative care program for lung cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Kentucky LEADS Collaborative Lung Cancer Survivorship Care program aims to improve the quality of life for lung cancer survivors through a novel survivorship care approach. This interventional study compares the effectiveness of the program against enhanced usual care in a randomized clinical trial involving 300 lung cancer survivors. The program incorporates patient-centered care principles, shared decision-making, and motivational interviewing to enhance survivor engagement and address the unique challenges faced by lung cancer patients, particularly in rural areas. The study is conducted in collaboration with multiple lung cancer care facilities in Kentucky.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Have been diagnosed with lung cancer
* Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
* Be at least 18 years of age or older
* Be able to communicate effectively in English

Exclusion Criteria:

* Have significant psychiatric disturbance that requires a higher level of care
* Have substance abuse/dependence that requires a higher level of care
* Are participating in another lung cancer survivorship care intervention
* Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program

Where it's running

• Markey Cancer Center
  Lexington, Kentucky, United States Recruiting

Study contacts

• Principal investigator: Jamie L Studts, PhD — University of Colorado School of Medicine
• Study coordinator: Jerod L Stapleton, PhD
• Email: jerod.stapleton@uky.edu
• Phone: 8593237224

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced COPD care for people being checked for lung cancer

  This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.

  Recruiting Region of Southern Denmark · Vejle · NCT07543601

• Pink and Pearl campaign to link mammography visits with lung cancer screening at Christian Hospital.

  This program will try to increase lung cancer screening among women aged 50–80 who come for mammograms at Christian Hospital.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT07146568

• Evaluating the Pink and Pearl Campaign for Lung Cancer Screening

  This study is testing if the Pink and Pearl Campaign can encourage women aged 50-80 getting mammograms to also get screened for lung cancer.

  Recruiting Washington University School of Medicine · Creve Coeur, Missouri · NCT06898333

• Rarecells blood test combining circulating tumor cell DNA and circulating tumor DNA for early lung cancer detection

  This test checks whether combining Rarecells ISET® circulating tumor cell DNA and circulating tumor DNA from a blood sample can find early or returning lung cancer in people with operable tumors.

  Recruiting Rarecells Diagnostics SAS · Roma · NCT06546007

• Erector spinae block for pain management in thoracic surgery

  This study is testing if a special pain relief technique using erector spinae blocks can help patients having lung surgery feel less pain and need fewer pain medications after their operation.

  Recruiting Phase 4 George Washington University · Washington D.C., District of Columbia · NCT05521789

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.